EQS-News: Michael Friede has been appointed Symrise Executive Board Member and President Scent & Care
Werte in diesem Artikel
EQS-News: Symrise AG
/ Key word(s): Personnel
Werbung Werbung Press release
The Supervisory Board of Symrise AG has appointed Michael Friede to the Executive Board. He will take over as President of the Scent & Care segment, which was ad-interim headed by CEO Dr. Jean-Yves Parisot. The Scent & Care segment, comprising Symrise's activities in fragrance applications, aroma molecules and cosmetic ingredients, generates annual sales of approximately EUR 2 billion. Michael König, Chairman of the Supervisory Board of Symrise AG: "We are very pleased to announce that Michael Friede will join us as a member of the Executive Board. He brings many years of broad market knowledge and a high level of industry-specific expertise in various growth areas. Additionally, he has proven international experience, making him an excellent choice for Symrise as a fast-growing, globally operating company." Werbung Werbung Michael Friede has been a member of the Management Board of Brenntag SE, Essen, Germany, since 2023, where he served as CEO of Brenntag Specialties leading the Life Science and Material Science specialty chemicals segments globally. Previously, he was a member of the Executive Committee of Akzo Nobel N.V. Amsterdam, the Netherlands, Executive Vice President at Covestro AG, Germany, and CEO and President of Covestro Elastomers SAS in France. He began his professional career at Bayer AG, where he held various management positions in Leverkusen, Germany, and Pittsburgh, USA. In addition, he is a Supervisory Board member of Pearl Polyurethane Systems LLC, a leading producer of polyurethane systems, headquartered in Dubai. Michael Friede (born in 1980), grew up in the county of Holzminden in southern Lower Saxony, studied in Madrid, Toronto, Essen, Oxford and London and holds both, a Master of Business Administration and a Bachelor of Science in Business Administration. He is married and has three children.
Werbung Werbung
About Symrise: Symrise is a global supplier of fragrances and flavors, cosmetic active ingredients as well as functional ingredients. Its customers include perfume, cosmetics, food and beverage manufacturers, the pharmaceutical industry and producers of dietary supplements and pet food. With sales of around €5 billion in the 2024 financial year, the company is one of the world's leading providers. The Group, headquartered in Holzminden, Germany, has more than 100 locations in Europe, Africa and the Middle East, Asia, North and Latin America. Together with its customers, Symrise develops new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked. Symrise – always inspiring more...
30.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
Language: | English |
Company: | Symrise AG |
Mühlenfeldstraße 1 | |
37603 Holzminden | |
Germany | |
Phone: | +49 (0)5531 90 0 |
E-mail: | ir@symrise.com |
Internet: | www.symrise.com |
ISIN: | DE000SYM9999, DE000SYM7787, DE000SYM7704 |
WKN: | SYM999 |
Indices: | DAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2176338 |
End of News | EQS News Service |
|
2176338 30.07.2025 CET/CEST
Ausgewählte Hebelprodukte auf Symrise
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Symrise
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Symrise AG
Analysen zu Symrise AG
Datum | Rating | Analyst | |
---|---|---|---|
30.07.2025 | Symrise Underperform | Jefferies & Company Inc. | |
30.07.2025 | Symrise Buy | UBS AG | |
30.07.2025 | Symrise Add | Baader Bank | |
30.07.2025 | Symrise Buy | Warburg Research | |
30.07.2025 | Symrise Overweight | JP Morgan Chase & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
30.07.2025 | Symrise Buy | UBS AG | |
30.07.2025 | Symrise Add | Baader Bank | |
30.07.2025 | Symrise Buy | Warburg Research | |
30.07.2025 | Symrise Overweight | JP Morgan Chase & Co. | |
25.07.2025 | Symrise Buy | Warburg Research |
Datum | Rating | Analyst | |
---|---|---|---|
01.07.2025 | Symrise Equal Weight | Barclays Capital | |
27.05.2025 | Symrise Hold | Jefferies & Company Inc. | |
06.05.2025 | Symrise Hold | Jefferies & Company Inc. | |
30.04.2025 | Symrise Neutral | Goldman Sachs Group Inc. | |
29.04.2025 | Symrise Hold | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
30.07.2025 | Symrise Underperform | Jefferies & Company Inc. | |
01.07.2025 | Symrise Underperform | Jefferies & Company Inc. | |
16.06.2025 | Symrise Underperform | Jefferies & Company Inc. | |
02.08.2024 | Symrise Sell | Goldman Sachs Group Inc. | |
01.08.2024 | Symrise Sell | Goldman Sachs Group Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Symrise AG nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen